Mary P. Moore

532 total citations · 1 hit paper
14 papers, 354 citations indexed

About

Mary P. Moore is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Mary P. Moore has authored 14 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 8 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Physiology. Recurrent topics in Mary P. Moore's work include Liver Disease Diagnosis and Treatment (12 papers), Diet, Metabolism, and Disease (8 papers) and Liver Disease and Transplantation (3 papers). Mary P. Moore is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Diet, Metabolism, and Disease (8 papers) and Liver Disease and Transplantation (3 papers). Mary P. Moore collaborates with scholars based in United States, Belgium and Italy. Mary P. Moore's co-authors include R. Scott Rector, Rory P. Cunningham, Elizabeth J. Parks, Jamal A. Ibdah, Alberto A. Diaz‐Arias, Andrew A. Wheeler, Grace M. Meers, Rama Ganga, Sarah A. Johnson and Ghassan M. Hammoud and has published in prestigious journals such as Hepatology, Diabetes and The FASEB Journal.

In The Last Decade

Mary P. Moore

14 papers receiving 352 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD

2022 147 citations Mary P. Moore, Rory P. Cunningham et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary P. Moore United States	8	259	135	123	92	47	14	354
Erika Paolini Italy	10	263 1.0×	101 0.7×	72 0.6×	130 1.4×	74 1.6×	27	407
Eline H. van den Berg Netherlands	14	370 1.4×	230 1.7×	103 0.8×	107 1.2×	29 0.6×	23	515
Maite Martinez‐Uña Spain	5	163 0.6×	80 0.6×	70 0.6×	109 1.2×	20 0.4×	7	289
Mariana Elorz Spain	11	307 1.2×	157 1.2×	124 1.0×	48 0.5×	29 0.6×	29	427
Anna Bobrus‐Chociej Poland	9	224 0.9×	104 0.8×	55 0.4×	96 1.0×	23 0.5×	27	348
Cynthia Melissa Valério Brazil	9	353 1.4×	210 1.6×	152 1.2×	207 2.3×	40 0.9×	21	631
Souveek Mitra India	3	288 1.1×	119 0.9×	66 0.5×	65 0.7×	20 0.4×	6	366
Ramchandra Ranvir India	8	221 0.9×	129 1.0×	49 0.4×	156 1.7×	32 0.7×	18	388
Fabrizio C. Lucchini Switzerland	7	164 0.6×	48 0.4×	131 1.1×	75 0.8×	39 0.8×	8	297
Barbara Fruci Italy	4	260 1.0×	216 1.6×	58 0.5×	125 1.4×	17 0.4×	4	384

Countries citing papers authored by Mary P. Moore

Since Specialization

Citations

This map shows the geographic impact of Mary P. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary P. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary P. Moore more than expected).

Fields of papers citing papers by Mary P. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary P. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary P. Moore. The network helps show where Mary P. Moore may publish in the future.

Co-authorship network of co-authors of Mary P. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Mary P. Moore. A scholar is included among the top collaborators of Mary P. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary P. Moore. Mary P. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Salvador, Amadeo F., Mary P. Moore, Jennifer M. Anderson, et al.. (2024). Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH. Journal of Hepatology. 81(5). 781–793. 20 indexed citations

Moore, Mary P., Xiaobo Wang, John P. Kennelly, et al.. (2024). Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulation. Hepatology. 81(2). 576–590. 7 indexed citations

Moore, Mary P., Grace M. Meers, Sarah A. Johnson, et al.. (2024). Relationship between serum β-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD. American Journal of Physiology-Endocrinology and Metabolism. 326(4). E493–E502. 12 indexed citations

Syed‐Abdul, Majid Mufaqam, Mary P. Moore, Andrew A. Wheeler, et al.. (2023). Isotope Labeling and Biochemical Assessment of Liver-Triacylglycerol in Patients with Different Levels of Histologically-Graded Liver Disease. Journal of Nutrition. 153(12). 3418–3429. 7 indexed citations

Wang, Xiaobo, Mary P. Moore, Hongxue Shi, et al.. (2023). Hepatocyte-targeted siTAZ therapy lowers liver fibrosis in NASH diet-fed chimeric mice with hepatocyte-humanized livers. Molecular Therapy — Methods & Clinical Development. 31. 101165–101165. 11 indexed citations

Moore, Mary P., Rory P. Cunningham, Grace M. Meers, et al.. (2022). Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD. Hepatology. 76(5). 1452–1465. 147 indexed citations breakdown →

Cunningham, Rory P., Mary P. Moore, Grace M. Meers, et al.. (2022). Hepatocyte‐specific eNOS deletion impairs exercise‐induced adaptations in hepatic mitochondrial function and autophagy. Obesity. 30(5). 1066–1078. 7 indexed citations

Syed‐Abdul, Majid Mufaqam, Mary P. Moore, Andrew A. Wheeler, et al.. (2021). Improvements in nonalcoholic fatty liver disease (NAFLD) after metabolic surgery is linked to an increased hepatic fatty acid oxidation—a case report. PubMed. 1. 4–4. 3 indexed citations

Cunningham, Rory P., Mary P. Moore, Grace M. Meers, et al.. (2021). Critical Role for Hepatocyte-Specific eNOS in NAFLD and NASH. Diabetes. 70(11). 2476–2491. 23 indexed citations

10.

Moore, Mary P., Rory P. Cunningham, Rachel Davis, et al.. (2021). A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 320(4). G564–G572. 20 indexed citations

11.

Moore, Mary P., et al.. (2020). A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD. Obesity. 28(10). 1843–1852. 84 indexed citations

12.

Cunningham, Rory P., et al.. (2019). Hepatic Knockdown of RECK Increases NASH Susceptibility. The FASEB Journal. 33(S1). 1 indexed citations

13.

Moore, Mary P., Rory P. Cunningham, James C. Healy, et al.. (2018). Curcumin Supplementation Mitigates NASH Development and Progression in Female Wistar Rats. Medicine & Science in Sports & Exercise. 50(5S). 724–724. 2 indexed citations

14.

Fitch, R. Holly, et al.. (1991). A warning to clinicians: metronidazole neurotoxicity in a dog. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact